Barely Significant
← all phrases

“an increasing trend”

63,972 sentences · 63,972 papers · 107,686 search hits before verification · confirmed specimen

Sighted at

p<0.09

Listed by Hankins (2013) · Otte et al. (2022)

In the literature

an increasing trendP <0.051.0× alphagold
Compared with sham group, MI groups for 2, 4, and 6 wk had an increasing trend on TAA, CSA, AR, and Media of the aorta (2, 4, and 6 wk, P <0.05 or P <0.01; Figure 7 and Table 4 ), while XJEK treatment for 2, 4, and 6 wk, the TAA, CSA, AR, and Media significantly decreased (2 wk, 4 wk, and 6wk, P <0.05 or P <0.01; Figure 6 and Table 3 ).
an increasing trendp > 0.051.0× alphagold
In addition, the wild-type showed an increasing trend in the immobility time (pre: 50.86 ± 6.18, post: 68.57 ± 6.48, p > 0.05, paired t -test) post CFA injection compared to that prior to CFA injection, whereas Kcnip3 -/- rats showed significantly increased immobility time (pre: 78.14 ± 7.98, post: 108.00 ± 7.06, p < 0.05, paired t -test), suggesting that Kcnip3 -/- rats are more vulnerable to depression than wild-type rats.
an increasing trendp < 0.051.0× alphagold
Overall increasing or decreasing trends in femoral diaphyseal OPD by region (Table 1 ) A regression analysis to test for the presence of continual increases or decreases in the overall OPD of the femoral diaphysis showed that, for femur A, the bone density exhibited an increasing trend in the distal direction for the medial region only ( p < 0.05); the other regions did not exhibit any clear trend.
an increasing trendp < 0.051.0× alphagold
MUC16 expression in pre and post-treatment groups using both drugs (methotrexate and cisplatin) was up-regulated and displayed an increasing trend in the placebo (4.31–5.11%), AF(D)NMs (6.13–6.36%) and IV-drug groups (7.67–8.14%) ( p < 0.05), whilst in the NMs (D) group, MUC16 expression was down-regulated (2.67–3.3%) ( Figure 11 ).
an increasing trendP>0.051.0× alphagold
Both LOM LSPV denervation and LSG Denervation significantly reduce cardiac sympathetic nervous activity (lower LF: 1.05±1.14 vs 2.36 ± 2.34 ms 2 in group 2 and 0.51 ± 0.39 vs 2.24 ± 1.53 ms 2 in group 3; and LF/HF ratio: 0.35±0.21 vs 1.65 ± 1.04 in group 2 and 0.27±0.28 vs 1.42 ± 0.77 in group 3; all P<0.05) but neither had a significant effect on parasympathetic nervous activity though which showed an increasing trend (HF: 2.69±2.00 vs 2.01 ± 2.14 in group 2 and 2.66±1.74 vs 1.95 ± 1.60 in group 3, P>0.05).